Elizabeth Buschur, M.D.
6700 UNIVERSITY BLVD STE 4C · Dublin, OH 43016
Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.
6700 UNIVERSITY BLVD STE 4C · Dublin, OH 43016
6700 University Boulevard · Dublin, OH 43016
92 North High Street · Dublin, OH 43017
4.8(575 Google reviews · 80 in past year)
6780 Longshore Street · Dublin, OH 43017
4.9(293 Google reviews · 38 in past year)
7537 Sawmill Road · Dublin, OH 43016
4.8(173 Google reviews · 10 in past year)
5728 Frantz Road · Dublin, OH 43016
4.9(145 Google reviews · 25 in past year)
5920 Wilcox Place · Dublin, OH 43016
4.3(116 Google reviews · 1 in past year)
6743 Dublin Center Drive · Dublin, OH 43017
5.0(44 Google reviews · 11 in past year)
20 North Street · Dublin, OH 43017
5.0(23 Google reviews · 16 in past year)
Pins reflect street addresses where available; others are approximate (ZIP-level).
No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Dublin or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.
They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.
Yes — 7 of the 18 tracked providers in this market indicate telehealth visits. State licensing rules determine whether a given telehealth practice can serve Ohio residents; confirm with the practice.
No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.
Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.